The dosage market size for Penicillins and Streptomycins in Ghana experienced fluctuations from 2012 to 2022. The market saw a decline in 2013 and 2019, with significant drops of -6.24% and -11.89% year-on-year respectively. Conversely, the market showed positive growth in years like 2014, 2015, 2016, 2017, 2018, and 2020, with the highest growth of 9.25% in 2020. Despite these fluctuations, the Compound Annual Growth Rate (CAGR) from 2012 to 2022 was generally positive, reflecting an overall incremental trend.
Specific CAGR values highlight interesting periods:
- 2016: 0.057%
- 2017: 2.46%
- 2018: 4.93%
- 2019: 1.41%
- 2020: 2.34%
- 2021: 1.57%
- 2022: -0.52%
Looking ahead to 2024 and beyond, critical trends to watch include potential impacts from healthcare policy changes, antibiotic resistance developments, and innovation in pharmaceutical technology. The balance between demand for penicillins and streptomycins versus advancements and discoveries of new alternatives will significantly shape the market landscape. Furthermore, socio-economic factors in Ghana will also play a crucial role in the market's future trajectory.
How does Ghana rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 25 | 25 Croatia | 22,712,000 | 2023 | +1.18% | +0.84% | View data |
| 26 | 26 Morocco | 20,047,000 | 2023 | -0.6% | -1.22% | View data |
| 27 | 27 Ghana | 19,904,000 | 2023 | +0.28% | -1.55% | |
| 28 | 28 Nicaragua | 15,976,000 | 2023 | -0.12% | +0.75% | View data |
| 29 | 29 Kyrgyzstan | 10,516,000 | 2023 | -0.4% | -0.84% | View data |
